PURPOSE: To analyze the early outcomes of viscosupplementation in patients with severe knee osteoarthritis. METHOD: A randomized, double-blind clinical trial of 143 knees divided into three groups: Group 1 - intra-articular injection of triamcinolone; Group 2 - hylan GF20; and Group 3 - triamcinolone + hylan GF20. Outcomes were evaluated using Lysholm and KSS scores before treatment and after one, three and six months. RESULTS: Within-group comparisons revealed improvements in Lysholm scores in all groups in the one month evaluation relative to pre-treatment levels (p < 0.01). This improvement was maintained in the third month after treatment (p > 0.05). Scores at six months were significantly lower than those observed in the previous follow-up assessments (p < 0.05), but still higher than pre-treatment levels (p < 0.05). KSS scores also improved after one month relative to pre-treatment levels (p < 0.01). This improvement was still present at three and six months after treatment in the corticosteroid group (p > 0.05). Patients treated with hylan GF20 showed lower scores in the last evaluation relative to month one (p < 0.05). No significant differences were observed between the treatment groups (p > 0.05). CONCLUSIONS: Viscosupplementation increased functional scores in patients with severe osteoarthritis of the knee, especially within three months of injection. However, it was not superior to the use of triamcinolone.
RCT Entities:
PURPOSE: To analyze the early outcomes of viscosupplementation in patients with severe knee osteoarthritis. METHOD: A randomized, double-blind clinical trial of 143 knees divided into three groups: Group 1 - intra-articular injection of triamcinolone; Group 2 - hylan GF20; and Group 3 - triamcinolone + hylan GF20. Outcomes were evaluated using Lysholm and KSS scores before treatment and after one, three and six months. RESULTS: Within-group comparisons revealed improvements in Lysholm scores in all groups in the one month evaluation relative to pre-treatment levels (p < 0.01). This improvement was maintained in the third month after treatment (p > 0.05). Scores at six months were significantly lower than those observed in the previous follow-up assessments (p < 0.05), but still higher than pre-treatment levels (p < 0.05). KSS scores also improved after one month relative to pre-treatment levels (p < 0.01). This improvement was still present at three and six months after treatment in the corticosteroid group (p > 0.05). Patients treated with hylan GF20 showed lower scores in the last evaluation relative to month one (p < 0.05). No significant differences were observed between the treatment groups (p > 0.05). CONCLUSIONS: Viscosupplementation increased functional scores in patients with severe osteoarthritis of the knee, especially within three months of injection. However, it was not superior to the use of triamcinolone.
Authors: C Tate Hepper; Jason J Halvorson; Stephen T Duncan; Andrew J M Gregory; Warren R Dunn; Kurt P Spindler Journal: J Am Acad Orthop Surg Date: 2009-10 Impact factor: 3.020
Authors: Kirk A Campbell; Brandon J Erickson; Bryan M Saltzman; Randy Mascarenhas; Bernard R Bach; Brian J Cole; Nikhil N Verma Journal: Arthroscopy Date: 2015-05-19 Impact factor: 4.772
Authors: Ahmed Samir Barakat; Nour Muhamad Ibrahim; Osama Elghobashy; Ahmed Maher Sultan; Khaled F M Abdel-Kader Journal: Int Orthop Date: 2019-06-22 Impact factor: 3.075
Authors: Dawid Bączkowicz; Grzegorz Skiba; Mirosław Szmajda; Ivan Vařeka; Krzysztof Falkowski; Kevin Laudner Journal: Cartilage Date: 2019-05-09 Impact factor: 4.634
Authors: Gustavo Constantino de Campos; Eduardo Branco de Sousa; Paulo César Hamdan; Cyro Scala de Almeida; Antonio Martins Tieppo; Marcia Uchôa de Rezende; Adrieni Antunes do Amaral Alchaar; Carlos Bruno Pinheiro; Eduardo de Melo Carvalho Rocha; Fabiano Gonçalves Cunha; Ivan Pacheco; Mário Sérgio Rossi Vieira; Sílvio Figueira Antonio; Zartur José Barcelos Menegassi Journal: Acta Ortop Bras Date: 2019 Jul-Aug Impact factor: 0.513
Authors: Alexander Wurm; Anna Zechling; Hermann Leitner; Dietmar Dammerer; Bernhard Pfeifer; Martin Krismer; Michael Liebensteiner Journal: Knee Surg Sports Traumatol Arthrosc Date: 2021-05-01 Impact factor: 4.114